Amorphous solid-dispersions
Dissolution Behavior of Amorphous Solid Dispersions
247
The production and characterization of fluoroquinolone amorphous solid dispersions
283
Evaluation and enhancement of physical stability of amorphous solid dispersions
103
Molecular Disorder of Bicalutamide - Amorphous Solid Dispersions Obtained by Solvent Methods
17
Generation of high drug loading amorphous solid dispersions by Spray Drying
8
Generation of high drug loading amorphous solid dispersions by Spray Drying
9
Real time Raman imaging to understand dissolution performance of amorphous solid dispersions
8
Model-based formulation of amorphous solid dispersions made by hot-melt extrusion
176
NOVEL AMORPHOUS SOLID DISPERSIONS OF CANAGLIFLOZIN HEMIHYDRATE IN EUDRAGIT® E PO
11
Amorphous solid dispersions of BCS class II drugs: a rational approach to solvent and polymer selection
12
Application of hot-melt extrusion in the manufacturing of amorphous solid dispersions containing thermally labile drugs
353
Article Relative contributions of Solubility and Mobility to the Stability of Amorphous Solid Dispersions of poorly soluble drugs: A Molecular Dynamics Simulation study
21
DEVELOPMENT AND CHARACTERIZATION OF NEVIRAPINE LOADED AMORPHOUS SOLID DISPERSIONS FOR SOLUBILITY ENHANCEMENT
7
Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling
11
Assessment of nanocomposites vs. amorphous solid dispersions for dissolution enhancement of bcs class ii drugs
370
Development of new screening methodologies and preparation methods with application in amorphous solid dispersions and pharmaceutical cocrystals
189
SOLVENT EVAPORATION METHOD FOR AMORPHOUS SOLID DISPERSIONS: PREDICTIVE TOOLS FOR IMPROVE THE DISSOLUTION RATE OF PIOGLITAZONE HYDROCHLORIDE
10
New directions in pharmaceutical amorphous materials and amorphous solid dispersions, a tribute to Professor George Zografi – Proceedings of the June 2016 Land O’Lakes Conference
14
Amorphous Solid Dispersions.pdf
702
Roles of surfactant and binary polymers on dissolution enhancement of bcs ii drugs from nanocomposites and amorphous solid dispersions
362